Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Imugene capital raise as early azer-cel data shows two complete responses
July 7, 2026 - - Latest News -
Uganda approves Galidesivir for compassionate use amid Bundibugyo Ebola outbreak
July 7, 2026 - - Latest News -
Early clinical imaging shows Syntara candidate reduces brain inflammation in people at high risk of Parkinson’s
July 7, 2026 - - Latest News -
Brandon Capital secures landmark Novartis acquisition of Myricx Bio
July 7, 2026 - - Latest News -
Australia must keep development manufacturing and jobs here to secure health and economic benefits
July 7, 2026 - - Latest News -
Regenerative breast scaffolds point to a new era in reconstructive surgery
July 2, 2026 - - Latest News -
BCAL takes stake in Genetic Signatures to broaden diagnostics capabilities
July 2, 2026 - - Latest News
